Codix Bio to produce HIV, malaria test kits amid USAid cutbacks

As African countries scramble to fill the gaps left by cutbacks on USAid funding, a manufacturer in Nigeria is planning on producing its own HIV and Malaria test kits. Codix Bio plans to make millions of these test kits at its new plant outside Lagos for the local and regional market, a company executive said.

By Ben Ezeamalu

20 Jun 2025

Image credit: Anna from Pixabay

The United States, the world's largest humanitarian aid donor, has cut funding for foreign assistance, half of which is delivered via USAid.

Wits University researchers are scrambling to manage the fallout from the decision by US President Donald Trump to slash funding to South Africa. Photo: Ihsaan Haffejee / GroundUp

Wits scrambles to lessen fallout from Trump’s funding cuts

Aisling de Lange 21 May 2025

The US support to Nigeria, which reached $740m in 2024 based on USAid data, is focused on preventing malaria and curbing HIV as well as delivering vaccines to local health centres across the country.

It is not yet clear how Nigeria will be affected by the cuts. The Nigerian government has said it will raise funds to continue some of the programmes that donors supported.

Codix Bio general manager Olanrewaju Balaja said the company will roll out kits later this month from its plant in partnership with the South Korean pharmaceutical producer SD Biosensor and support from the World Health Organiation (WHO).

Kenya HIV patients live in fear as US aid freeze strands drugs in warehouse

Aaron Ross, Tim Cocks and Vivianne Wandera 13 Mar 2025

The plant has an initial capacity to produce 147 million kits annually, but this can be expanded to over 160 million.

"From the statistics of what is supplied (by USAid and Pepfar) for a specific programme year, and looking at what we have currently in capacity for Nigeria, we have enough capacity to meet the demand," Balaja told Reuters.

He said if the company scaled up operations, "we can go to west and sub-Saharan Africa, including other African countries."

Nigeria has the highest burden of malaria globally, according to WHO, with nearly 27% of the global burden. The country also has the world's fourth highest burden of HIV, according to UNAids.

In the 2000s activists across the world campaigned for antiretroviral treatment to be made available to people with HIV. One of the consequences of this was PEPFAR, the United States government’s foreign aid HIV programme. Since 2003 it has saved millions of lives. But now its future is unclear. Photo from the Treatment Action Campaign’s march for HIV treatment in Cape Town on 14 February 2003. (photographer unknown)

Trump’s sudden suspension of foreign aid puts millions of lives in Africa at risk

Liezl Human 23 Jan 2025

"The focus was for us to be able to play in the field of supply of rapid diagnostic test kits for donor agencies, which particularly USAid was at the forefront," Balaja added.

Balaja said the Nigerian government and donor agencies like Global Fund were expected to purchase test kits from Codix Bio.

Source: Reuters

Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day.

Go to: https://www.reuters.com/